Advisory expert group
As part of the development and marketing strategy of LIB-01, Dicot has entered into agreements with key opinion leaders and experts in the research and medical profession. The purpose of the group is to help in profiling Dicot's drug candidate and preparing it for market authorization.
To date, Dicot has entered into agreements with the following experts:
Kerstin Fugl-Meyer - Professor emerita in social work, with a focus on clinical sexology at Karolinska Institutet.
Professor Fugl-Meyer has been the author of more than 140 scientific publications within clinical research, including extensive clinical trial studies. Professor Fugl-Meyer works for Dicot as a consultant in the fields of sexology and clinical trials and is assisting Dicot in creating clinical networks in the field of sexology in Europe.
François Giuliano – Medical Doctor and PhD, Neuro-Urology Andrology, Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, Garches, France and Associate Professor of Therapeutics (Paris-Ile de France Ouest Medical University).
Francois is one of three founders of Pelvipharm, a CRO specializing in preclinical models concerning pharmacological treatment of cardiovascular diseases, sexual dysfunction in women and men, and non-malignant diseases in the lower urinary tract.
Delphine Behr-Roussel - PhD, Cardiovascular Pharmacology at the University of Paris IV.
Delphine is the CEO and Head of R&D at Pelvipharm, a CRO specializing in preclinical models related to pharmacological treatment of cardiovascular disease, sexual dysfunction in women and men, and non-malignant diseases of the lower urinary tract.